Holen Sie sich die Stockscreener-App
1.80
0.55%
-0.01
Bioharvest Sciences Inc Aktie (BHST) Neueste Nachrichten
BioHarvest Sciences Inc. (NASDAQ: BHST) to Initiate Dual Listing on Tel Aviv Stock Exchange for 22.7M Shares - Kalkine Media
Tel Aviv listing on deck for BioHarvest (NASDAQ: BHST). Trading is expected to start in 2026. - Stock Titan
Small cap wrap: Tiziana Life Sciences, Thistle Resources, Alvopetro, BioHarvest... - Proactive financial news
BioHarvest Sciences to dual-list shares on Tel Aviv exchange By Investing.com - Investing.com Nigeria
BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing - Yahoo Finance
BioHarvest Sciences to dual-list shares on Tel Aviv exchange - Investing.com
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) - marketscreener.com
BioHarvest Sciences Inc.'s Growth Strategy Progress Update #3 Live Video Conference November 19, 2020 @ 2:00pm E.S.T - TMX Newsfile
BioHarvest Sciences: Patented plant cell culture platform drives scalable growth and strong revenue outlook - TradingView
BioHarvest (BHST) Daily Price Brief: Finishes 2.76% Down at $2.11 at the Close; Session Range View: Price Remains Between $2.00 Support and $2.22 Resistance in Latest TradingLow Volatility Picks - vinanet.vn
BioHarvest (BHST) Earnings Recap: The Available Earnings Metric Delivers a Miss in the Reported Period; The Stock Loses 1.15% in the Available RecordEarnings Manipulation Risk - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
BHST Looks 70.0% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
BioHarvest Sciences Inc. Common Stock (NASDAQ: BHST) Stock Price, News & Analysis - Kalkine
BHST Q1 2025 Earnings: Wider-Than-Expected Loss Sends Shares DownEarnings Trend Analysis - vinanet.vn
BioHarvest Sciences Inc. (NASDAQ:BHST) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
BHST Maintains Rating by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
BioHarvest Sciences Inc. (BHST) Jumps 6%: Breaking Toward Resistance at $2.31Gap Down Bounce Plays - Vinanet
BHST Maintained by Roth Capital -- Price Target Lowered to $8.00 - GuruFocus
BioHarvest at canaccord growth conference: scaling plant-cell platform By Investing.com - Investing.com Canada
BioHarvest Sciences: Patented cell culture platform secures $20–30M fragrance deal, targets $40M revenue and profitability - TradingView
BioHarvest at canaccord growth conference: scaling plant-cell platform - Investing.com
BioHarvest Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Maxim Group Maintains BioHarvest Sciences(BHST.US) With Buy Rating, Maintains Target Price $5 - Moomoo
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript - AOL.com
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlight - GuruFocus
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... - Yahoo Finance
What Could BioHarvest Sciences (NASDAQ:BHST) Quarterly Update Show? - Kalkine Media
What Will BioHarvest Sciences (NASDAQ:BHST) Add to Nasdaq Focus? - Kalkine Media
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss By Investing.com - Investing.com Canada
What Is BioHarvest Sciences (NASDAQ:BHST) Nasdaq Composite Focus? - kalkinemedia.com
BioHarvest Sciences cuts FY26 sales guidance to $37-40 million - scanx.trade
Transcript : BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
BioHarvest Sciences Q2 Earnings Call Highlights - marketbeat.com
BioHarvest Sciences: Secured first major CDMO contract and reaffirmed 2027 EBITDA breakeven despite revised 2026 guidance - TradingView
BioHarvest Sciences: Secured a transformative fragrance CDMO contract, driving revenue growth and 2027 EBITDA breakeven - TradingView
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss - Investing.com
BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound - finance.yahoo.com
BioHarvest Sciences shares surge 11% after major fragrance manufacturing deal - Yahoo Finance
BioHarvest Sciences shares surge 11% on major fragrance deal By Investing.com - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
BioHarvest secures fragrance manufacturing deal worth $20-30M By Investing.com - Investing.com Australia
BioHarvest secures first CDMO manufacturing dea... - pluang.com
BioHarvest Sciences shares surge 11% on major fragrance deal - Investing.com
BioHarvest Sciences: Q2 revenue up 3.8% to $8.8M; first CDMO deal signed; full-year guidance revised downward - TradingView
BioHarvest secures fragrance manufacturing deal worth $20-30M - Investing.com
BioHarvest Sciences Reports Q2 2026 Results, Secures First CDMO Fragrance Manufacturing Agreement for 20-Ton Production Program - kalkine.ca
BioHarvest inks exclusive deal to produce rare luxury fragrance, targeting $20-$30M revenue by 2027. - Pluang
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance - TMX Newsfile
BioHarvest Sciences Lands Exclusive 20-Tonne Rare Fragrance Production Deal Worth $20–$30 Million - Kalkine Media
Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Gardner leaders tour Biosynth to boost local economy - AOL.com
0.95%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):